1-3 of 3
Shinya Osone
Close
Sort by
Journal Articles

Leukemic Cells Expressing ETV6-Frk Identified in a Refractory B-ALL Patient Are Sensitive to Dasatinib in Vitro

Azusa Mayumi, Hideki Yoshida, Kouhei Mitsuno, Nozomi Nishida, Shinya Osone, Takahiko Yasuda, Toshihiko Imamura
Journal: Blood
Blood (2021) 138 (Supplement 1): 4335.
https://doi.org/10.1182/blood-2021-149926
Published: 2021
Journal Articles

Coagulation and Fibrinolysis Imbalance Demonstrated By Novel Simultaneous Thrombin and Plasmin Generation Assay during L-Asparaginase Treatment Phase of Induction Therapy in Pediatric Acute Lymphoblastic Leukemia

Takashi Ishihara, MD, Keiji Nogami, MD PhD, Satoshi Ochi, MD, Toshiaki Ishida, MD PhD, Yoshiyuki Kosaka, MD PhD, Akihisa Sawada, MD PhD, Masami Inoue, MD, Shinya Osone, MD PhD, Toshihiko Imamura, MD PhD, Hajime Hosoi, MD PhD, Midori Shima, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3972.
https://doi.org/10.1182/blood-2018-99-110411
Published: 2018
Journal Articles

ABT-737 Restores Prednisolone Sensitivity In Early T-Cell Precursor Acute Lymphoblastic Leukemia With High MEF2C Expression

Sachiko Goto, MD, Toshihiko Imamura, MD, Atsushi Fujiki, MD, Takuya Nakatani, MD, Yoshifumi Hirashima, MD, Shinichi Tamura, MD, Shinya Osone, MD, Hiroyuki Ishida, MD, Akira Morimoto, MD, Hiroshi Kuroda, MD, Shigeyoshi Hibi, MD, Shinsaku Imashuku, MD, Hajime Hosoi, MD
Journal: Blood
Blood (2013) 122 (21): 3830.
https://doi.org/10.1182/blood.V122.21.3830.3830
Published: 2013